These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7369735)

  • 41. Comparative ultrastructural studies of nucleoli of tumor cells treated with adriamycin and the newer anthracyclines, carminomycin and marcellomycin.
    Daskal Y; Woodard C; Crooke ST; Busch H
    Cancer Res; 1978 Feb; 38(2):467-73. PubMed ID: 202387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of amphotericin B on Adriamycin transport in P388 cells.
    Krishan A; Sauerteig A; Gordon K
    Cancer Res; 1985 Sep; 45(9):4097-102. PubMed ID: 4028003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Action of carminomycin on leukemic cell proliferation and some problems of its use in the combined therapy of leukemias].
    Egorov LV; Khanykova OK; Kuznetsova TV; Rudneva NA; Kozinets GI
    Antibiotiki; 1978 Sep; 23(9):833-6. PubMed ID: 697341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Action of the antitumor antibiotics, rubomycin and carminomycin, on the T- and B-cell population ratio in mouse lymphoid organs].
    Vatin AE
    Antibiotiki; 1980 Nov; 25(11):860-4. PubMed ID: 6969571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Suppression of DNA synthesis in mice by the anthracycline antibiotics daunorubicin, carminomycin and doxorubicin].
    Reznikova MI; Dudnik IuV
    Antibiot Khimioter; 1988 Apr; 33(4):286-9. PubMed ID: 3389958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative evaluation of the myelotoxic action of rubomycin, adriamycin and carminomycin by their delayed effects in an experiment].
    Fursov SE; Novitskiĭ VV; Fedorenko EN; Gol'dberg ED
    Antibiot Med Biotekhnol; 1985 Apr; 30(4):284-8. PubMed ID: 4026249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antiviral action of carminomycin and some of its derivatives].
    Liashenko VA; Shapovalova SP; Aleksander SK; Povarov LS
    Antibiotiki; 1978 Nov; 23(11):1009-15. PubMed ID: 214027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative study of the effects of carminomycin 13-cyclohexylidenehydrazone and carminomycin on several immunologic responses of the body].
    Malkova IV; Shapovalova SP
    Antibiotiki; 1984 May; 29(5):374-7. PubMed ID: 6378085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The influence on tumor growth and the function of the thiol-dependent systems of the liver of excess cooking fat and vitamin E in the diet. The effects of carminomycin].
    Tazhibaev ShS; Lenskaia EG; Alekseeva NR; Sisemalieva ZhS; Monakhov BV
    Vopr Pitan; 1990; (3):47-51. PubMed ID: 2399682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antitumor properties and toxicity of a carminomycin and protein complex].
    Liashenko VA; Aleksander SK
    Antibiotiki; 1978 Nov; 23(11):1005-9. PubMed ID: 581438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Synthesis and antitumor properties of rubomycin 13-cyclohexylidene hydrazone].
    Tarasova VE; Ul'ianova LA; Povarov LS; Odnoralets EN
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):27-31. PubMed ID: 3566226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Morphological characteristics of the pathomorphosis of acute leukemias treated with rubomycin and carminomycin].
    Popov VM; Vinogorova GF
    Probl Gematol Pereliv Krovi; 1980 Jul; 25(7):9-13. PubMed ID: 6931366
    [No Abstract]   [Full Text] [Related]  

  • 53. [Study of the toxicity of carminomycin 13-cyclohexylidenhydrazone].
    Shepelevtseva NG; Vertogradova TP; Belova IP; Gol'dberg LE
    Antibiotiki; 1983 Feb; 28(2):90-5. PubMed ID: 6838184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
    Takahashi Y; Kinoshita M; Masuda T; Tatsuta K; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Jan; 35(1):117-8. PubMed ID: 7068512
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparison of carminomycin and rubomycin action on the dynamics of the immune response to the T-independent Vi-antigen of S. typhi].
    Malkova IV
    Antibiotiki; 1980 Feb; 25(2):140-4. PubMed ID: 6965576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of amphotericin B on the diuretic action of diacarb and various indicators of water-salt metabolism in healthy and tumor-bearing animals].
    Bychkov IA; Pashinskiĭ VG; Iaremenko KV; Zoloev GK
    Antibiotiki; 1984 Nov; 29(11):837-40. PubMed ID: 6549254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Production of a murine lymphadenosis NK/LY resistant to rubomycin and a comparison of the cellular DNA histograms of the sensitive and resistant lines].
    Prokhorova EV; Merkulova IB; Shelaputina ZF
    Antibiotiki; 1980 May; 25(5):370-4. PubMed ID: 7387132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial conversion of daunomycin, carminomycin I and feudomycin A to adriamycin.
    Oki T; Takatsuki Y; Tobe H; Yoshimoto A; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Sep; 34(9):1229-31. PubMed ID: 7328065
    [No Abstract]   [Full Text] [Related]  

  • 59. [Carminomycin in the therapy of leukemias].
    Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG
    Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161
    [No Abstract]   [Full Text] [Related]  

  • 60. Anthracycline mechanisms in analogue selection.
    Acton EM
    Drugs Exp Clin Res; 1985; 11(1):1-8. PubMed ID: 3915272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.